Renalytix - Income from Continuous Operations 2020-2024 | RNLXY
Renalytix - income from continuous operations from 2020 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Renalytix - Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-33 |
| 2023 | $-46 |
| 2022 | $-45 |
| 2021 | $-35 |
| 2020 | $-10 |
| 2019 | $0 |
| 2019 | $-42 |
| Renalytix - Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-7 |
| 2024-03-31 | $-8 |
| 2023-12-31 | $-8 |
| 2023-09-30 | $-10 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-12 |
| 2022-12-31 | $-10 |
| 2022-09-30 | $-12 |
| 2022-06-30 | $-5 |
| 2022-03-31 | $-15 |
| 2021-12-31 | $-15 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $-10 |
| 2021-03-31 | $-9 |
| 2020-12-31 | $-9 |
| 2020-09-30 | $-8 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-1 |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.031B | $0.002B |
| Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.883B | 59.65 |
| Hims & Hers Health (HIMS) | United States | $14.668B | 152.40 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Tempus AI (TEM) | United States | $10.008B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.472B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.870B | 60.47 |
| Hinge Health (HNGE) | United States | $3.513B | 0.00 |
| Privia Health (PRVA) | United States | $2.388B | 163.25 |
| 10x Genomics (TXG) | United States | $1.713B | 0.00 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Enovis (ENOV) | United States | $1.544B | 8.61 |
| Azenta (AZTA) | United States | $1.530B | 71.11 |
| Schrodinger (SDGR) | United States | $1.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 24.55 |
| Evolent Health (EVH) | United States | $1.162B | 99.00 |
| Claritev (CTEV) | United States | $0.636B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.532B | 0.00 |
| Standard BioTools (LAB) | United States | $0.524B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| TruBridge (TBRG) | United States | $0.315B | 698.67 |
| Outset Medical (OM) | United States | $0.300B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.175B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |